Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice
- PMID: 28003153
- DOI: 10.1016/j.bbi.2016.12.014
Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice
Abstract
Activation of the inflammasome is implicated in the pathogenesis of an increasing number of inflammatory diseases, including Alzheimer's disease (AD). Research reporting inflammatory changes in post mortem brain tissue of individuals with AD and GWAS data have convincingly demonstrated that neuroinflammation is likely to be a key driver of the disease. This, together with the evidence that genetic variants in the NLRP3 gene impact on the risk of developing late-onset AD, indicates that targetting inflammation offers a therapeutic opportunity. Here, we examined the effect of the small molecule inhibitor of the NLRP3 inflammasome, MCC950, on microglia in vitro and in vivo. The findings indicate that MCC950 inhibited LPS+Aβ-induced caspase 1 activation in microglia and this was accompanied by IL-1β release, without inducing pyroptosis. We demonstrate that MCC950 also inhibited inflammasome activation and microglial activation in the APP/PS1 mouse model of AD. Furthermore, MCC950 stimulated Aβ phagocytosis in vitro, and it reduced Aβ accumulation in APP/PS1 mice, which was associated with improved cognitive function. These data suggest that activation of the inflammasome contributes to amyloid accumulation and to the deterioration of neuronal function in APP/PS1 mice and demonstrate that blocking assembly of the inflammasome may prove to be a valuable strategy for attenuating changes that negatively impact on neuronal function.
Keywords: APP/PS1 mice; Alzheimer’s disease; Caspase 1; Inflammasome; Interleukin-1β; Microglia; Neuroinflammation.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.CNS Neurosci Ther. 2018 Dec;24(12):1207-1218. doi: 10.1111/cns.12983. Epub 2018 Jun 4. CNS Neurosci Ther. 2018. PMID: 29869390 Free PMC article.
-
Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.Neurobiol Dis. 2018 Sep;117:15-27. doi: 10.1016/j.nbd.2018.05.016. Epub 2018 May 30. Neurobiol Dis. 2018. PMID: 29859317
-
α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1-42-stimulated murine astrocytes.J Neuroinflammation. 2018 Sep 27;15(1):282. doi: 10.1186/s12974-018-1319-x. J Neuroinflammation. 2018. PMID: 30261895 Free PMC article.
-
Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.Neurochem Res. 2020 Nov;45(11):2560-2572. doi: 10.1007/s11064-020-03121-z. Epub 2020 Sep 14. Neurochem Res. 2020. PMID: 32929691 Review.
-
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions.Arch Pharm (Weinheim). 2024 Nov;357(11):e2400459. doi: 10.1002/ardp.202400459. Epub 2024 Aug 23. Arch Pharm (Weinheim). 2024. PMID: 39180246 Review.
Cited by
-
Huang-Pu-Tong-Qiao Formula Alleviates Hippocampal Neuron Damage by Inhibiting NLRP3 Inflammasome-mediated Pyroptosis in Alzheimer's Disease.Mol Neurobiol. 2025 Apr;62(4):4545-4561. doi: 10.1007/s12035-024-04547-0. Epub 2024 Oct 28. Mol Neurobiol. 2025. PMID: 39466576
-
Role of pyroptosis in the pathogenesis of various neurological diseases.Brain Behav Immun. 2024 Mar;117:428-446. doi: 10.1016/j.bbi.2024.02.001. Epub 2024 Feb 7. Brain Behav Immun. 2024. PMID: 38336022 Free PMC article. Review.
-
Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease.Brain Sci. 2024 Jan 19;14(1):96. doi: 10.3390/brainsci14010096. Brain Sci. 2024. PMID: 38275516 Free PMC article. Review.
-
TNEA therapy promotes the autophagic degradation of NLRP3 inflammasome in a transgenic mouse model of Alzheimer's disease via TFEB/TFE3 activation.J Neuroinflammation. 2023 Feb 2;20(1):21. doi: 10.1186/s12974-023-02698-w. J Neuroinflammation. 2023. PMID: 36732771 Free PMC article.
-
NLRP3/Caspase-1 Pathway-Induced Pyroptosis Mediated Cognitive Deficits in a Mouse Model of Sepsis-Associated Encephalopathy.Inflammation. 2019 Feb;42(1):306-318. doi: 10.1007/s10753-018-0894-4. Inflammation. 2019. PMID: 30276509 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources